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Despite female athlete health becoming a growing area of interest in sport science 
reasearch, there are still gaps to be filled in the literature. Low energy availabilty 
(LEA) and iron deficiency are two prevalent issues in women (or female athletes)  
that are under high loads of exercise stress from training. Thus, it is critical that 
measurement and identification of these parameters is accurate. The first part of 
this thesis reviews the literature surrounding LEA and iron deficiency with a focus 
on current identification techniques used in research and clinical settings. The 
second part of this thesis includes two original investigations. The first study, 
Chapter 2, had two aims; 1) to investigate the test-retest reliabilty of an indirect 
calorimetry analyser (Parvo Medics TrueOne), and 2) compare measured RMR 
with three RMR-predictive (pRMR) equations in female athletes. To address the 
first aim, 12 recreationally-exercising women (mean ± SD; age 27.5 ± 12.3 y) 
performed two RMR assessments, on separate days, utilising the Parvo Medics 
TrueOne analyser. To address the second aim, 25 females (mean ± SD; age 30.1 ± 
10.2 y) underwent an RMR assessment using the Parvo Medics TrueOne analyser, 
which was compared to three calculated pRMR equations (Harris-Benedict [H-B], 
Mifflin-St Jeor [M], World Health Organisation [WHO]). Test-retest reliability for 
the TrueOne analyser was deemed acceptable (CV = 5.3%, ICC = 0.92). The validity 
of pRMR when compared to measured RMR showed low levels of agreement in all 
3 predictive equations (M: CV = 21.4%, TEE = 269 kcal×day-1, r = 0.16, WHO: CV = 
21.5%, TEE = 270 kcal×day-1, r = 0.13 H-B: CV = 21.6%, TEE = 270 kcal×day-1, r = 0.13).   
 iii 
The second study, Chapter 3, was designed to investigate specific health 
parameters related to iron, resting metabolic rate and energy balance in a cohort 
of highly-trained women. Thirteen highly-trained female endurance athletes 
(mean ± SD; age 32 ± 7 y, training volume 18.5 ± 4.1 hrs) provided a blood test to 
assess iron markers (haemoglobin [Hb], haematocrit [Hct], C-reactive protein 
[Crp], serum iron, serum ferritin and transferrin). Additional measures included 
resting metabolic rate (RMR) assessment, dual-energy x-ray absorptiometry (DXA) 
scans, diet and training diaries and menstrual cycle tracking to identify any 
additional risk factors which may be associated with relative energy deficiency in 
sport. Analysis revealed that 46% (6/13) of this population had iron levels below 
optimal. Serum iron, serum ferritin and transferrin were all significantly decreased 
in the iron deficient (ID) group (p < 0.05). When compared to the non-iron 
deficient (non-ID) group haemoglobin (Hb) and haematocrit (Hct) were 
significantly lower in the ID group compared with the non-ID group (p < 0.05). The 
relationship between Crp and serum iron revealed a large negative correlation (r 
= -0.66), Crp and serum ferritin a very large negative correlation (r = -0.72) and 
transferrin presented a large correlation with Crp (r = 0.70). In conclusion, the 
outcomes of these studies demonstrate the need for greater stratification of risk 
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The format of this thesis includes four chapters; Chapter One contains a review of 
relevant literature surorunding female athlete health, specifically, resting 
metabolic rate (RMR) and iron deficiency, to introduce the reader to current 
practices and highlight any gaps in the literature. Chapter Two is an original 
investigation of RMR reliability and validity when compared to predicitve 
equations. This chapter is presented in the style of an individual journal article as 
it has been submitted for review in the journal of Performance Enhancement and 
Health, therefore some information may be repeated throughout this thesis. 
Chapter Three investigates iron staus, inflammation and bone health in a group of 
non-professional highly- trained female endurance athletes. Finally, Chapter Four, 
summarises the findings of both Chapter Two and Chapter Three and provides 
practical applications as well as suggested areas for further investigation in this 






















Female athletes are at a higher risk of clinical health issues than their male 
counterparts due to different physiological adaptations, dietary requirements and 
hormonal status (Ahmadi, Enayatizadeh, Akbarzadeh, Asadi, & Tabatabaee, 2010; 
McClung, Gaffney-Stomberg, & Lee, 2014; Warren & Perlroth, 2001). Female 
endurance athletes, in particular, face a unique set of challenges to maintain both 
optimal health and performance (Melin et al., 2015). Iron deficiency (ID) is 
reported to affect 60% of female athletes on varying scales of intensity (Cowell, 
Rosenbloom, Skinner, & Summers, 2003). While women are susceptible to 
suboptimal iron status due to negative iron balance contributed by inadequate 
dietary intake as well as losses through menstruation, female athletes may have a 
greater risk due to increased iron losses associated with hemolysis, sweating, 
gastrointestinal bleeding and exercise-induced acute inflammation (Auersperger 
et al., 2013; Ma, Patterson, Gieschen, & Bodary, 2013; Peeling, Dawson, 
Goodman, Landers, & Trinder, 2008). Often associated with female athlete health 
also is low energy availability (LEA). LEA is a condition that occurs when there is an 
imbalance between energy expenditure from exercise training and energy intake, 
is often an under-identified, but impactful health concern of female athletes. LEA 
is associated with a myriad of health issues such as menstrual dysfunction, 
compromised reproductive function, impaired bone health and thyroid function, 
and overall decreased athletic performance (De Souza et al., 2014; De Souza & 
Williams, 2004; Petkus, Murray-Kolb, & De Souza, 2017). These components are 
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collectively referred to Relative Energy Deficiency in Sport (REDs) (Mountjoy et al., 
2014). 
A subset of research is present in current literature in agreement with the 
deleterious effects female endurance athletes could (potentially) encounter if 
they develop an iron deficiency or fall into a state of LEA for extended periods 
(Mountjoy et al., 2014; Petkus et al., 2017; Slater, Brown, McLay-Cooke, & Black, 
2017). While screening for risk factors of low iron, LEA and other symptoms of 
REDs are now starting to be implemented in high performance sport settings 
(Thein-Nissenbaum & Hammer, 2017), knowledge and awareness is still lacking in 
school-age through to non-professional elite athletes which puts them at a higher 
risk of long-term health issues and performance decreases (Hoch et al., 2009). This 
review aims to investigate current research underpinning iron deficiency and LEA 
in female athletes, with a focus on gaps in the literature that could provide better 
insight to prevention and screening techniques in female athletes below the 
professional threshold.  
Section One: Iron Status in Female Athletes  
Female endurance athletes are most at risk for low iron intake; an essential 
micronutrient in energy production pathways and a functional component of 
hemoglobin and myoglobin. Iron is necessary to aid in both physiological and 
cognitive functions of the body through the transportation of oxygen to active 
tissue (Beard, 2001). Additionally, iron plays an important role in the electron 
transport chain promoting oxidative phosphorylation, critical to general health 
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and athletic performance (Peeling et al., 2008; Rowland, 2012). Due to fluctuations 
across the menstrual cycle stored iron levels are somewhat variable in females, 
however, it is estimated to be around 2.5 g (Clenin et al., 2015). Of this stored iron, 
1-2 g is generally lost during daily function (Nielsen & Nachtigall, 1998) with 
augmented iron losses shown in athletes (Shaskey & Green, 2000). These losses 
are recovered through dietary intake, via the consumption of heme, (found in 
meat products), and non-heme iron (occurring in vegetables and fortified cereals). 
The daily recommended iron intake for females is 18 mg/day (McClung et al., 
2014). When iron stores are not recovered through adequate dietary intake, the 
body becomes depleted and if sustained, an iron deficiency may develop 
(Malczewska, Raczynski, & Stupnicki, 2000).  
Identifying iron deficiency  
It is known that increased prevalence of iron deficiency in female athletes is 
common (Table 1.), however discrepancies around what classifies iron deficiency 
still exist. Archer and Brugnara (2015) reference three stages of iron deficiency: a) 
‘storage iron depletion’ where a drop in serum ferritin may be noticed however 
there are no significant haematological changes present; b) ‘iron deficiency non-
anaemic’ where there may be an observed drop in haemoglobin (Hb) levels as well 
as other biochemical markers, however this could still be inside normal reference 
ranges and; c) ‘iron deficiency anaemia’ where multiple biochemical markers are 
outside normal reference ranges. While stage 3 (iron deficiency anaemia) is the 
most severe, all three stages of iron deficiency could have adverse effects on 
athletic performance (Clenin et al., 2015). Garvican and colleagues (2014), 
 5 
investigated athletic performance and changes in iron deficiency in 27 highly-
trained distance runners (with existing low iron stores, but not anaemia). Using 
intravenous iron supplementation for 6-weeks they noticed an increase in iron 
stores which may have also enhanced endurance capacity through erythropoiesis, 




Table 1. Prevalence of iron deficiency (ID) in physically active females. 
Reference Subjects sFer cut off value used (ug/L) Prevalence of ID 
Alaunyte et al. (2014) 11 female distance runners (age: 32 ± 7 y) <12 36% 
Auersperger et al. (2013) 
14 female runners. ID group (n = 7, age: 34.9 ± 4.7 y) & Non ID 
group (n =7, age: 31.4 ± 5.9 y) 
<20 50% 
Choe et al. (2001) 72 physically active females (age: 15-17 y) <12 21% 
Clement et al. (1987) 36 female winter Olympic athletes <30 39% 
Constantini et al. (2000) 25 female gymnasts (age: 13.5 ± 1.6 y) <20 33% 
DellaValle & Haas (2012) 
48 female rowers grouped by iron status. ID (n = 24, age: 19.6 ± 
1.1 y) & Non ID (n =24, age: 20.1 ± 1.1 y) 
<20 27% 
Di Santolo et al. (2008) 70 female athletes from various sports (age: 24.0 ± 4.22 y) <12 27% 
Gropper et al. (2006) 70 collegiate female athletes from various sports (age: 18-25 y) <15 24% 
Koehler et al. (2012) 97 female athletes of various sports (age: 16.3 ± 3.0 y) <35 57% 
Malczewska et al. (2001)  121 female athletes from various sports (age: 21.5 ± 3.4 y) <20 26% 




Ostojic & Ahmetovic (2008) 15 female distance runners <12 20% 
Pate et al. (1993) 111 female runners (age: 29.9 ± 7.2 y) <20 50% 
Sandstrom et al. (2012) 
57 female high school athletes of various sports (age: 16.8 ± 
0.97 y) 
<16 52% 
Sinclair & Hinton (2005) 72 active females (age: 18-41 y) <16 29% 
Spodaryk et al. (1996) 40 female athletes from various sports <20 20% 
Woolf et al. (2009) 28 highly-active female (age: 20 ± 2 y) <12 21% 
 * ID - Iron Deficient, sFer - Serum Ferritin 
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Serum ferritin (sFer) is a valid marker for determining iron deficiency (Jacobs & 
Worwood, 1975); however, variability in this marker exists in female athletes as 
inflammation and infection can cause serum ferritin levels to differ from iron 
storage status, consequently inferring a false negative diagnosis of ID (Van den 
Bosch et al., 2001). Other markers such as serum iron, serum transferrin, and 
transferrin may also be used in the identification of an iron deficiency (Archer & 
Brugnara, 2015). The sFer threshold indicative of an iron deficiency in the 
literature is inconsistent however and can range from <12 g/L to 35 g/L ferritin 
(Burden, Morton, Richards, Whyte, & Pedlar, 2015; Di Santolo et al., 2008; Milic et 
al., 2011; Pate et al., 1993; Peeling et al., 2007) creating uncertainty when 
comparing results. It has been suggested that athletes, especially endurance-
based athletes, have increased losses leading to a higher prevalence of iron 
depletion (Nachtigall, Nielsen, Fischer, Engelhardt, & Gabbe, 1996; Sinclair & 
Hinton, 2005) indicating the need for a standardised threshold in athletes that 
differs to current clinical guidelines based on a sedentary population (Wians, 
2018). 
Effect of iron deficiency on athletic performance  
It is well established that decreased iron status has an undesirable effect on 
general health. Research suggests an iron deficiency (with and without anemia) 
may compromise immune function, impair cognitive function and decrease 
metabolic efficiency as well as compromise overall bone health (Beard, 2001; 
DellaValle & Haas, 2011; Toxqui & Vaquero, 2015). Through the human 
performance lens, VO2max (an individuals’ maximal rate of aerobic energy capacity) 
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is fundamental to successful performance in endurance-oriented sports such as 
(mid-long distance) running, swimming, rowing and cycling (Costill, Thomason, & 
Roberts, 1973; Saltin & Astrand, 1967). As iron is an essential element to oxidative 
metabolism, diminished iron status can impair aerobic capacity, therefore 
reducing overall endurance performance (Hinton, Giordano, Brownlie, & Haas, 
2000; Rowland, Deisroth, Green, & Kelleher, 1988).  
Section Two: Low Energy Availability in Female Athletes  
A growing number of female athletes, from recreational to elite, suffer from low 
energy availability (LEA) (Table 2.). LEA can be induced when energy intake is 
reduced, energy expenditure is increased, or (most commonly) a combination of 
the two (Loucks, Kiens, & Wright, 2011). LEA, not other factors associated with 
exercise, causes the development of exercise-induced amenorrhea, iron 
deficiency, and other physiological perturbations associated with REDs (Mountjoy 
et al., 2014).  
Effects of LEA on health and wellbeing  
Increased energy expenditure, combined with decreased energy intake can lead 
to adaptive neuroendocrine changes which result in the down regulation of many 
hormones that contribute to reproductive function (Lagowska & Kapczuk, 2016; 
Lagowska, Kapczuk, Friebe, & Bajerska, 2014; Melin et al., 2015; Muia, Wright, 
Onywera, & Kuria, 2016; VanHeest, Rodgers, Mahoney, & De Souza, 2014). 
Alongside this, it has also been observed that athletes showing signs of LEA have 
a lower RMR than those in energy balance (Melin et al., 2015). Original findings in 
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the literature deemed that hormonal balance is disrupted below the threshold of 
30 kcal×kg/day-1 relative to lean body mass/day-1 (Loucks & Thuma, 2003), 
although there is evidence to suggest that below 45 kcal×kg/LBM/day-1 is sub-
optimal for normal function (Hoch et al., 2009; Melin et al., 2015). As little as 5-
days below this threshold (>30 kcal×kg LBM/day-1) has been shown to cause 
noticeable reductions in hypothalamic-pituitary-axis hormones, disrupting 





Table 2. Prevalence of low energy availability (LEA) in physically active females. 
Reference Subjects Prevalence of LEA  Comments 
Day et al. (2015) 25 Division 1 female runners (age: 19.5 ± 1.8 y) 53% 
This study acknowledges optimal EA to be <45 
kcal×kg/LBM/day-1. 92% of subjects were below this. Average 
EA = 30.7 kcal×kg/LBM/day-1 
De Souza et al. (1998) 24 female exercisers (mean age: 27.8 y) 100% 
When compared to a sedentary cohort EA was significantly 
lower in the exercising population (p  < 0.05) 
Doyle-Lucas et al. (2010) 
15 professional female ballet dancers (mean 
age: 24.3 y) 
100% 
When compared to a sedentary cohort EA was significantly 
lower in the dancers (p < 0.01) 
Koehler et al. (2013) 
185 female athletes from various sports (age: 
16.3 ± 2.8 y) 
50% 
Didn't take into account below optimal levels of EA in this 
study 
Lagowska & Kapczuk (2016) 
31  female athletes (age: 18.1 ± 2.6 y) & 21 
female ballet dancers (age: 17.1 ± 0.9 y) 
100% of the ballet 
dancers, unclear in female 
athlete subjects. 
EA was low in both study populations with athletes presenting 
EA levels of 28.3 ± 9.2 kcal×kg/LBM/day-1 and ballet dancers 
slightly lower with 21.7 ± 7.2 kcal×kg/LBM/day-1 
Melin et al. (2015) 
25 female endurance athletes (age: 26.6 ± 5.6 
y) 
12% 44% were below optimal EA (<45 kcal×kg/LBM/day-1) 
Muia et al. (2016) 56 female athletes (runners) (age: 16-17 y) 17.9% 
Nearly 100% presented as below optimal (<45 
kcal×kg/LBM/day-1) (EA = 36.5 ± 4.5 kcal×kg/LBM/day-1) 
Reed et al. (2013) 
19 Division 1 female soccer players (age: 19.23 
± 0.3 y) 
26% at baseline 
measurement 
Average EA was noticeably lower in the middle of the season 
compared to pre and post season levels 
Schaal et al. (2011) 
10 competitive female endurance athletes. 
Separated into eumenorrheic (n = 5, age: 29.8 
± 2.5 y) and amenorrheic (n = 5, age: 31.0 ± 
4.3 y) 
100% in both groups 
EA was 29 ± 4.8 kcal.kg/LBM/day in the eumenorrheic group 
and 18 ± 6.6 kcal.kg/LBM/day in the amenorrheic group 
Schaal et al. (2017) 
9 elite female synchronized swimmers (age: 
20.4 ± 0.4 y) 
100% at baseline 
measurement 
Baseline EA was 25.1 ± 1.8 kcal×kg/LBM/day-1 and further 
reduced to 17.8 ± 2.8 kcal×kg/LBM/day-1 after 4-weeks of 




Silva & Pavia (2015) 67 rhythmic gymnasts (age: 18.7 ± 2.9 y) 44.80% 
EA = 31.5 ± 11.9kcal×kg/LBM/day-1 , when separated by age 
the older group (19-26 y, n = 31) had a lower EA (29.8 ± 10.8  
kcal×kg/LBM/day-1 ) 
Vanheest et al. (2014) 
10 junior elite female swimmers (age: 15-17 y). 
Separated into cyclic (n = 5) and ovarian 
suppressed (n = 5). 
100% of ovarian 
suppressed subjects. 
Over a 12-week training program cyclic were in positive 
balance in weeks 2 and 4 but had a great EA than ovarian 
suppressed across the entire study 
Viner et al. (2015) 
4 female competitive cyclists (age: 38.4 ±10.3 
y) 
100% (across a cycling 
season) 
EA was 26.2 ± 14.1 kcal×kg/LBM/day-1 in pre-season, 25.5 ± 3.1 
kcal×kg/LBM/day-1 in competition season and 23.8 ± 8.9 
kcal×kg/LBM/day-1 during off-season 
Woodruff & Meloche (2013) 10 female volleyball players (mean age:  20.9y) 20% 60% had LEA levels below optimal (<45 kcal×kg/LBM/day-1 ) 





Decreased bone mineral density (BMD) is another area of concern for athletes with 
LEA. Bone formation is suppressed when energy availability (EA) falls under a 
threshold of 30 kcal.kg/LBM/day
-1
 (Ihle & Loucks, 2004). When combined with an up-
regulation of bone reabsorption, athletes can face serious health consequences 
including increased short-term risk factors for stress fractures (Barrack, Ackerman, & 
Gibbs, 2013; Boutroy, Bouxsein, Munoz, & Delmas, 2005) or more long-term damage 
resulting in osteoporosis (Golden & Abrams, 2014). In a study of 29 healthy females, 
Ihle and Loucks (2004) found that even in short-term phases of energy restriction (as 
little as 5-days) bone reabsorption was increased and bone formation suppressed 
when EA fell below a threshold of 30 kcal×kg/LBM/day-1 . Left untreated this could lead 
to long-term reductions in BMD. 
Effects of LEA on athletic performance  
Logue et al. (2018) determined that depletion of glycogen stores (associated with a 
decrease in energy intake [EI]) impairs physical performance, as well as mental 
capacity, by increasing the risk of dehydration, increasing circulating lactate and 
overall reducing aerobic and strength-based performance. Decreased levels of 
performance in the exercise protocol (walking on a treadmill) were recorded after a 
depletion of blood glucose levels for as little as 5-days in 29 habitually sedentary 
females (Loucks & Thuma, 2003). The same has been shown in athletes over a longer 
period of decreased EA. In a study of swimmers, a 9.8% decline in 400 m swim time 
was recorded over a 12-week training season in ovarian-suppressed athletes 
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compared with an 8.2% increase in performance in their normally menstruating 
counterparts (VanHeest et al., 2014). VanHeest (2014) also confirms the questioned  
link between ovarian suppression and LEA, results showed a strong correlation 
between energy availability and total triiodothyronine (a measure often used to 
assess thyroid function) (r = 0.76). Moreover, LEA may exacerbate poor sports 
performance concomitantly through loss of lean body mass, decreased RMR,  and 
electrolyte imbalances (El Ghoch, Soave, Calugi, & Dalle Grave, 2013). 
Screening techniques in the literature 
In order to diagnose LEA, both energy intake and energy expenditure need to be 
quantified, supplemented with additional measurements of bone mineral density, 
body composition, and menstrual function (Logue et al., 2018). Thresholds in the 
literature for determining LEA can range from 30 kcal.kg/LBM/day
-1
 – 45 
kcal.kg/LBM/day
-1
 (Table 2.). Methodology surrounding the measurement of energy 
expenditure and intake is variable in the literature (De Souza et al., 1998; Gibbs, 
Williams, & De Souza, 2013; J.  Reed et al., 2013; Silva & Paiva, 2015; VanHeest et al., 
2014). Inaccurate measurement of daily expenditure could result in the under or over-
estimation of required energy intake to maintain a healthy energy balance, putting 
subjects at risk of LEA if sustained for an extended period. Using RMR as a measure 
for energy availability could be more sustainable than measurement of energy intake 
and expenditure outside a laboratory due to the unreliable nature of self-reported 
food and activity logs (Donahoo, Levine, & Melanson, 2004). 
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Researchers (Harris & Benedict, 1918; Mifflin et al., 1990) have developed predictive 
equations by which an individual can predict their own RMR by inserting individual 
data, which may prove to be valuable in the field for practitioners without metabolic 
gas exchange equipment or access to biomarkers. Studies have shown that predictive 
equations may be useful in large scale studies that require a cost-effective method of 
measuring RMR (Flack, Siders, Johnson, & Roemmich, 2016; Hasson, Howe, Jones, & 
Freedson, 2011), although validity in assessing RMR through predictive equations in 
an athletic population is yet to be confirmed.  
Section Three: The Crossroads of LEA and ID in Female Athletes 
When combined with LEA, data indicates the effects of low iron stores could be 
exacerbated. Athletes with low energy intake (< 2000 kcal×day-1) have been associated 
with a higher risk of iron deficiency (Economos, Bortz, & Nelson, 1993). DellaValle and 
colleagues (2011, 2012) investigated performance times of  female colligate rowers, 
who were energy deficient (ED) and iron deficient (without anemia), and those with 
ED and ID were reported to have slower 4 km time-trial times, lower VO2peak, and 
reduced energy efficiency compared than athletes that were energy replete. Research 
is now emerging to determine the dual effects that the crossroads of ID and LEA pose 
on women, and specifically female athletes. In a review by Petkus et al. (2017) this 
crossroad was thoroughly examined concluding that iron deficiency may further 
potentiate the hypometabolic state that is induced by LEA. Iron deficiency may further 
compromise reproductive health, impair bone development, and impair athletic 
 
 16 
performance due to interacting effects that induce hypothyroidism (Goncalves, 
Resende, Fernandes, & da Costa, 2006; Haouari et al., 1994; Harvey et al., 2005; 
Moschonis et al., 2013; Toxqui & Vaquero, 2015).  
Section Four: Conclusions/Recommendations for Further Research  
This review highlights the potential issues that female athletes (especially but not 
limited to, female endurance athletes) are facing as they participate in larger volumes 
of intensive training. Most research to date focuses on sedentary or recreationally-
active females with a small cohort of research being presented on high-performance 
athletes. Here lies a gap where females that are highly-trained but not classified as 
professional fall. The current literature demonstrates that health and performance 
concerns due to a reduction in energy availability and/or reduced iron stores are 
present in female athletes, however there is very little agreement on how these issues 
can be identified and diagnosed. While there is basic screening in elite high-
performance cohorts, where health professionals are trained to understand the 
demands of performing at a high level in the sporting arena, non-professional athletes 
and exercisers have no such support. Further research should aim to establish 
thresholds to identify health issues such as energy and iron deficiency in athletic 
populations. Furthermore, these thresholds should be established in both the clinical 
and research settings to ensure female athletes are able to train and exercise to their 
potential, in a healthy and sustainable way. More research is needed to assist health 
professionals in the identification of exercise and nutrition induced health problems 
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Study 1: The validity of resting metabolic 
rate (RMR)-prediction equations and 
reliability of the Parvo Medics TrueOne 
analyser for measuring RMR in female 
athletes 
This chapter appears in the same format that was required by the journal 
Performance Enhancement & Health where it has been submitted for publication.  
Citation: Mackay, K., Driller, M., & Sims, S. (2018). The validity of resting metabolic 
rate (RMR)-prediction equations and the reliability of the Parvo Medics TrueOne 






Purpose: The aim of the current study was to; 1) assess the test-retest reliability of an 
indirect calorimetry analyser (Parvo Medics TrueOne), and 2) compare measured 
RMR with three RMR-predictive (pRMR) equations in female athletes. Methods: In 
part one, 12 recreationally-exercising women (mean ± SD; age 27.5 ± 12.3 y) 
performed two RMR assessments, on separate days, utilising the Parvo Medics 
TrueOne analyser. In part two, 25 women, ranging from recreationally-exercising to 
highly-trained athletes (mean ± SD; age 30.1 ± 10.2 y) underwent an RMR assessment 
using the Parvo Medics TrueOne analyser, which was compared to three calculated 
pRMR equations (Harris-Benedict (H-B), Mifflin-St Jeor (M), World Health 
Organisation (WHO)). Results: Test-retest reliability for the TrueOne analyser was 
deemed acceptable (CV = 5.3%, ICC = 0.92). The validity of pRMR when compared to 
measured RMR showed low levels of agreement in all 3 predictive equations (M: CV 
= 21.4%, TEE = 269 kcal×day-1, r = 0.16, WHO: CV = 21.5%, TEE = 270 kcal×day-1, r = 0.13 
H-B: CV = 21.6%, TEE = 270 kcal×day-1, r = 0.13).  Conclusion: The Parvo Medics 
TrueOne analyser is a reliable tool for measuring RMR. Caution should be taken when 
using pRMR equations in female athletes, however, in sub-elite female athlete 
populations, predictive equations may be more accurate than in their lesser-trained 
counterparts.  
KEYWORDS: resting metabolic rate; energy deficiency; REDs; Harris-Benedict; Mifflin 




Disturbances in energy balance resulting in a state of energy deficiency can 
compromise overall health status (Mountjoy et al., 2014) and may have a negative 
impact on sport performance in athletic populations (Loucks et al., 2011). Accurate 
identification of energy deficiency typically involves the measurement of resting 
metabolic rate (RMR) often in conjunction with hormonal profiling (De Souza et al., 
2007) and energy balance monitoring  (Brown, Howatson, Quin, Redding, & 
Stevenson, 2016), Given that RMR is a commonly used assessment tool (Crenshaw, 
2009; Melin et al., 2015; J. Reed, De Souza, Mallinson, Scheid, & Williams, 2015) for 
the identification of energy deficiency in athletes, the accuracy and reliability of the 
assessment is critical.  
RMR measured by indirect calorimetry provides information at rest by measuring the 
volume of oxygen consumption (VO2), volume of carbon dioxide production (VCO2), 
and respiratory exchange ratio (RER = VCO2 / VO2). RMR values can then be used in 
combination with hormonal profile and energy balance measures to formulate an 
overall picture of energy availability. Energy availability describes the balance 
between energy in and energy expenditure, thus the validity and reliability of RMR 
measurement tools is crucial. The Parvo Medics TrueOne analyser (TrueOne 2400, 
Parvo Medics, Sandy UT) is often used in sport science laboratory settings to measure 
RMR as it has been  reported to be a valid measurement tool for assessing RMR  
against the Deltatrac II (VIASYS Healthcare, Inc., SensorMedics, Yorba Linda, CA) 
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(Cooper et al., 2009) and the Douglas Bag system (Woods, Garvican-Lewis, Rice, & 
Thompson, 2016) in male recreational and elite athletic populations. However, the 
test-retest reliability of the TrueOne in the recreationally trained female athletic 
populations is yet to be determined.  
The use of pRMR equations is extensive in metabolic research literature as these tests 
are inexpensive and easy to administer. The validity of the pRMR equations comes 
into question when deviating from the original population from which they were 
developed (Bonganha et al., 2013). For example, the three most frequently used 
pRMR equations are the Harris-Benedict, the Mifflin-St Jeor, and the World Health 
Organisation (WHO) equations. The Harris-Benedict equation was developed and 
validated in the early 1900’s.  For the validation, 136 male (age: 27 ± 9 y) and 103 
female participants (age: 31 ± 14 y) took part in the (initial) study (Harris & Benedict, 
1918) and the formula has been studied extensively ever since. The Mifflin-St Jeor 
equation was derived from a sample of 498 (female n=247, male n=251) average-
weight (f = 54.9 ± 4.5 kg, m = 68.5 ± 5.8 kg), overweight (f = 63.7 ± 5.5 kg, m = 80.2 ± 
7.5 kg), obese (f = 76.2 ± 6.6 kg, m = 92.2 ± 7.3 kg), and severely obese (f = 89.4 ± 11.0 
kg, m = 108.7 ± 13.1 kg) with individuals aged from 19 to 78 years (45 ± 14 y). The 
World Health Organisation (WHO) equation was developed using data mostly derived 
from young European military and police recruits, including 2,279 men and 247 
women with 45% of the cohort of Italian descent. While all three RMR-prediction 
equations have been studied extensively for both their validity and reliability, across 
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a range of populations, the equations have yet to be validated against measured RMR 
values in a recreationally trained female-athlete population. The aim of the current 
study was to determine the reliability of the Parvo Medics TrueOne indirect 
calorimetry analyser for measuring RMR in a recreationally active female population. 
A secondary aim of the study was to assess the validity of three pRMR equations 
relative to the measured RMR values in both recreationally active female athletes and 
highly-trained, non-professional female athletes. 
2. Methods 
2.1 Participants 
Part one (measured RMR): Twelve recreationally trained females (VO2max; 40.2 ± 5.6 
mL×kg/min-1) (mean ± SD; age 27.5 ± 12.3 y, weekly exercise duration 8.0 ± 3.6 h×wk-1, 
height 169.3 ± 7.3 cm, body mass 69 ± 9.4 kg, body mass index 24 ± 3) volunteered to 
participate in the study.  
Part two (measured RMR and predicted RMR): Twenty-five female athletes 
(recreationally active and highly-trained) volunteered to participate in this study. 
Criteria for inclusion as a recreationally trained female comprised of being free of any 
illness or injury and a minimum exercise requirement of at least 3 h×wk-1. Inclusion 
criteria for the sub-elite population compromised of being free of any illness or injury, 
be currently regularly training (>10 h×wk-1), and having represented New Zealand in 
their given sport in the last 3 y. The two groups comprised of recreational female 
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athletes (n=12) (mean ± SD; age 27.5 ± 12.3 y, weekly exercise duration 8.0 ± 3.6 h.wk
-
1
, height 169.3 ± 7.3 cm, body mass 69 ± 9.4 kg, body mass index 24 ± 3) and sub-elite 
female athletes (n=13) (mean ± SD; age 32.5 ± 7.4 y, weekly exercise duration 16.0 ± 
4.0 hr×wk-1, height 167.9 ± 5.8 cm, body mass 60.9 ± 6.7 kg, body mass index 22 ± 2) 
(see Table 3.)  All participants provided informed written consent and the study 
received ethical approval from the University of Waikato Human Research Ethics 
Committee (HREC (Health) 2017 #13). 
2.2 Study design 
Part I: 
On two separate occasions, 12 recreationally trained female athletes participated in 
a test-retest reliability study, performing RMR measurements in our laboratory, with 
each trial separated by a minimum of 24 h and a maximum of 5 days. 
Part II:  
Twenty-five female athletes (recreational (n = 12) to sub-elite (n = 13)) performed one 
RMR assessment using the Parvo Medics TrueOne analyser. The measured RMR was 





Table 3. Participant characteristics grouped by training status.  
 Data shown as mean ± SD. 
 




Age (y) 27.5 ± 12.3 32.5 ± 7.4 
Height (cm) 169.3 ± 7.3 167.9 ± 7.8 
Body Mass (kg) 69 ± 9.4 60.9 ± 6.7 
Body Mass Index 24 ± 3 22 ± 2 
Weekly Exercise Duration (h×wk-1) 8.0 ± 3.6 16.0 ± 4.0 
 
25 
2.3 Measurement  
Measured RMR was conducted using the ‘RMR’ function on the TrueOne metabolic 
analyser (TrueOne 2400, Parvo Medics, Sandy UT). On the morning of the 
assessments, participants arrived at the laboratory for their scheduled lab 
appointment (between 0600 and 0830 h) following an overnight fast of >10 h, with 
participants refraining from caffeine and alcohol intake >24 h prior to testing. 
Participants were instructed to sleep (at least) 8 h the night before testing and 
recorded their 24 h dietary intake prior to the first trial to be replicated prior to the 
second trial. Participants were also asked to refrain from exercise in the 24 h leading 
up to each RMR assessment. Both trials were performed at the same time of day to 
control for any diurnal variation. Participants were to arrive at the laboratory in a 
relaxed and rested state and were instructed to perform minimal activity between 
waking and arrival to the RMR testing session. Upon arrival to the laboratory 
participants height (cm) and body mass (kg; in minimal clothing) were measured 
before a 5-min passive rest period prior to the RMR assessment. (Compher, 
Frankenfield, Keim, Roth-Yousey, & Group, 2006). 
2.4 Protocols  
Participants were asked to relax and lie supine on a bed with the head rest set at an 
incline of 45° during the 20-min assessment period, but to maintain alertness with 
eyes open. The canopy (Figure 1) was then placed over the head, shoulders and upper 
chest of the participant to reduce contaminant air entering or expired air escaping 
 
26 
during measurement. Flow rate was established at 28 to 30 ml×min-1 within the first 4 
min of the assessment as per manufacturer’s instructions. Expired air was sampled 
every 15 s. Data was averaged over 30 s and the participants file was exported in 
Microsoft Excel format for subsequent calculation of RMR (kcal×day-1). RMR was 
calculated using the average of the final minute of each 5-min segment of the 







2.5 RMR-predictive equations (pRMR) 
Three RMR-prediction (pRMR) equations were calculated in the current study for 
comparison to the measured RMR value. The timeframe with the highest level of 
reliability during the RMR assessment (e.g. 4-5, 9-10, 14-15, 19-20 min) was used for 
comparison to the pRMR equations. All pRMR equations listed have been described 
elsewhere (Harris & Benedict, 1918; James, 1985; Mifflin et al., 1990; Ramirez-
Marrero, Edens, Joyner, & Curry, 2014). 




The Harris Benedict equation was calculated as follows: 
Eq. 1) RMR = 655 + (9.6 × BM) + (1.7 × H) – (4.4 × A) 
The Mifflin-St Jeor equation was calculated as follows: 
Eq. 2) RMR = (9.99 × BM) + (6.25 × H) − (4.92 × A) - 161 
The World Health Organisation equation was calculated as follows: 
Eq. 3) RMR = (13.3 × BM + 334 × (H/100)) + 35 
Where BM = body mass (kg), H = height (cm) and A = age (y) 
2.6 Statistical analysis 
All data is presented as mean ± SD unless stated otherwise. Statistical significance was 
set at p < 0.05. Comparison of the pRMR with measured RMR assessment was 
achieved using a Students’ paired t-test, Pearson product-moment correlation 
analysis, 95% limits of agreement (LOA), mean bias (%), and typical error of estimate 
(TEE). While correlation analysis indicates the degree to which two variables are 
associated, it does not necessarily indicate the extent to which values agree or 
disagree. To overcome this limitation, the approach of quantifying the level of 
agreement between the methods measuring the same parameter (in this case RMR) 
was employed (Altman & Bland, 1983; Atkinson & Nevill, 1998). The mean difference 
between methods (2 standard deviations or 95% of a normally distributed population) 
was determined. The TEE and mean bias between methods was determined using an 
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excel spreadsheet (Hopkins, 2017), with the TEE expressed both in raw units and as a  
coefficient of variation (CV) percentage. The magnitude of correlation between the 
predicted and actual RMR values was assessed with the following thresholds: <0.1, 
trivial; <0.1 to 0.3, small; <0.3 to 0.5, moderate; <0.5 to 0.7, large; <0.7 to 0.9, very 
large; and <0.9 to 1.0, almost perfect.  
Test-retest reliability data was analysed using an Excel spreadsheet for reliability 
(Hopkins, 2017). TEE and overall reliability of RMR is presented as coefficient of 
variation (CV%) and as an absolute value (kcal×day-1) along with intra-class correlation 
coefficients (ICC’s), and upper and lower 90% confidence intervals (CI). 
3. Results 
3.1 Reliability of RMR measurement 
RMR was observed as an almost perfect agreement between trials 1 and 2 for the 19-
20 min timeframe of the test (TEE = 62 kcal×day-1, CV = 5.3%, ICC = 0.92, Table 4). RMR 
measures were less reliable in the 0-15 min timeframes, with CV’s ranging from 7.0-
11.1% (Table 4). 
 
3.2 Validity of RMR-prediction equations 
The validity of all three predictive equations when compared to measured RMR was 
questionable, with low levels of agreement (Table 5). Mifflin-St Jeor showed only a 
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small level of agreement (CV = 21.4%, TEE = 269 kcal×day-1, r = 0.16), followed closely 
by the WHO equation (CV = 21.5%, TEE = 270 kcal×day-1, r = 0.13) and the Harris-
Benedict (CV = 21.6%, TEE = 270 kcal×day-1, r = 0.13). Bland-Altman plots for 
agreement between the three predictive equations and measured RMR are shown in 




















Figure 2. The level of agreement plots (Bland-Altman) showing ±95% limits of 
agreement (represented as dashed lines) between the measured RMR and each of the 
RMR prediction equation values in all female athletes (recreational to sub-elite): (a) 
RMR vs. Harris-Benedict (HB); b) RMR vs. Mifflin-St Jeor (Mifflin); c) RMR vs. World 
Health Organisation (WHO)). Solid black line represents the difference between 
methods. Grey line represents linear line of best fit. 
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Data was then separated to examine training status effect of two groups: 
recreationally trained female athletes (n=12) and; sub-elite female athletes (n=13). 
Results are presented in Table 6. Between groups there was a significant difference in 
measured RMR values (p < 0.01). In recreationally trained female athletes, the 
equation that showed the highest agreement to measured RMR was the Mifflin-St 
Jeor equation (CV = 12.9%, TEE = 148 kcal×day-1, r = 0.69), followed by the WHO 
equation (CV = 13.0%, TEE = 150 kcal×day-1, r = 0.68) and then the Harris-Benedict (CV 
= 14.5%, TEE = 162 kcal×day-1, r = 0.61) (Table 6). In sub-elite female athletes, the 
equation that showed the highest agreement to measured RMR was the Mifflin-St 
Jeor (CV = 8.1%, TEE = 131 kcal×day-1, r = 0.75), followed the WHO (CV = 8.5%, TEE = 





Table 4. Test-retest reliability outcomes for resting metabolic rate (RMR) expressed as typical error of estimate (TEE), coefficient of 
variation (CV%) and Intra-class correlation coefficient (ICC). 
 







(Mean ± SD) 
Trial 2 
(Mean ± SD) 
 (90% CI)  (90% CI)  (90% CI) 
4 to 5-min 1332 ± 243 1253 ± 227 143 (107 - 222) 
10.5 
(7.8 – 16.8) 
0.66 
(0.27 - 0.86) 
9 to 10-min 1227 ± 175 1307 ± 192 88 (66 - 137) 
7.0 
(5.2 – 11.1) 
0.80 
(0.53 - 0.93) 
14 to 15-min 1216 ± 229 1273 ± 222 126 (94 - 196) 
11.1 
(8.2 – 17.7) 
0.73 
(0.38 - 0.89) 








Table 5. Comparison of measured RMR and three RMR-prediction equations in all female athletes (recreational to sub-elite). Mean 
bias, range of mean difference (95% limits of agreement or ±2SD) typical error of estimate (TEE – raw and CV%) and Pearson’s 




















Measured RMR 1452 ± 267 - - - - - 
Harris-Benedict 1438 ± 113 -14 
(-108 - 80) 
-554 - 526 270 
(218 - 358) 
21.6 
(17.1 – 29.5) 
0.13 
(-0.22 - 0.45) 
Mifflin-St Jeor 1392 ± 140 -61 
(-157 - 36) 
-611 - 490 
 
269 
(217 - 356) 
21.4 
(17.0 – 29.4) 
0.16 
(-0.19 – 0.47) 
World Health 
Organisation 
1460 ± 133 7 
(-89 - 104) 
-544 - 559 
 
270 
(218 - 358) 
21.5 






Table 6. Comparison of measured RMR and three RMR-prediction equations in sub-elite athletes and recreational athletes. Typical 
error of estimate (TEE – raw and CV%) and Pearson’s correlation coefficient (r) between methods. 
* represents significant difference between groups (p < 0.01). # represents significant difference when compared to Measured RMR (p < 0.01). 
 RMR 
(kcal×day-1) 

























1629 ± 189* 1260 ± 195* 
 




1391 ± 81# 1484  ± 128# 
 
-234 
(-305 - -163) 
224 
(144 - 304) 
 
139 
(104 - 216) 
162 
(120 - 259) 
 
8.5 
(6.3 – 13.5) 
14.5 
(10.5 – 24.0) 
 
0.71 
(0.35 – 0.89) 
0.61 





1366 ± 102# 1451  ± 155# 
 
-293 
(-358 - -228) 
191 
(117 - 265) 
 
131 
(98 - 203) 
148 
(109 - 236) 
 
8.1 
(6.0 – 12.9) 
12.9 
(9.4 – 21.3) 
 
0.75 
(0.42 – 0.90) 
0.69 




1405 ± 102# 1518  ± 141# 
 
-224 
(-291 - -157) 
258 
(184 - 332) 
 
138 
(103 - 213) 
150 
(111 - 239) 
 
8.5 
(6.3 – 13.5) 
13.0 
(9.5 – 21.5) 
 
0.72 
(0.37 – 0.89) 
0.68 





The current study assessed the reliability of the Parvo Medics TrueOne analyser as 
a method of indirect calorimetry for assessing RMR in a recreationally trained 
female athlete population. The study also compared measured RMR values to 
those obtained through three commonly used pRMR equations in 25 female 
athletes. The main findings of this study were a) the Parvo Medics TrueOne 
analyser resulted in almost perfect levels of test-retest reliability and; b) the three 
pRMR equations analysed in the present study overestimated the RMR in the 
recreationally trained female athlete cohort, however, in the sub-elite population 
of female athletes, the predictive equations underestimated RMR and showed a 
higher correlation. 
The test-retest reliability of the Parvo Medics TrueOne analyser for measuring 
RMR in the current study is in agreement with previous studies; Woods and 
colleagues (2016) reported a test-retest reliability CV of ~6.5 % for the same 
analyser in a mixed population of male and female endurance athletes. Woods et 
al. (2016) employed an onsite protocol to minimize the influence of activities of 
daily living, such as rising from bed, dressing and transport to the laboratory (e.g. 
participants performed RMR measures on waking). While this was not performed, 
and is a potential limitation to the current study, it is interesting to note that our 
study resulted in higher levels of reliability. This may be related to the differences 
in protocol used (e.g. mouthpiece in exercise mode vs. canopy/hood in RMR 
mode); or potentially, the studied population all being exercisers and a more 
uniform cohort (mixed vs. single sex only). Similar to the current study, Cooper et 
 
36 
al. (2009) reported a CV of 4.8% for test-retest reliability of the Parvo Medics 
TrueOne analyser.  
Compher et al. (2006) recommends that a CV <10% is sufficient for the 
measurement of resting energy status. Based on this recommendation, the pRMR 
equations used in the current study were inappropriate for estimating RMR in the 
female recreational athletes, however, in sub-elite female athletes, the equations 
were valid in estimating RMR. Results from the recreational female athletes in our 
study produced CV’s of between 12.9 – 14.0% when compared to our indirect 
calorimetry analyser, with all three equations over-predicting RMR values. The 
Mifflin-St Jeor equation was the closest predictive value, with a CV of 12.9% and a 
mean bias of 191 kcal×day-1.  
The pRMR equations underestimated RMR by 131-139 kcal.day-1 in the sub-elite 
female athletes. The current findings align with observations of Flack and 
colleagues (2016) which indicated that as fat free mass increased, the predictive 
equations further underestimated RMR which may explain the underestimation 
of the sub-elite female athlete population. Although fat-free mass was not 
measured in the current study, it is assumed, due to the literature on body 
composition and female athletes, that a greater percentage of body mass is of lean 
muscle in this cohort. Hasson et al. (2011) also observed an underestimation using 
the Mifflin-St Jeor equation when participants were classified as within a normal 
weight range in both males and females.  
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In other research by Bullough, Gillette, Harris, and Melby (1995) it has been 
reported that people who expend large amounts of energy and also match this 
expenditure with large amounts of energy intake were shown to have an elevated 
RMR. Conversely, RMR is reduced when large amounts of energy is expended and 
energy intake is decreased. Tremblay et al. (1986) also demonstrated this 
relationship of low energy intake suppressing overall RMR. This could explain the 
significantly lower measured RMR in our recreationally-exercising females 
compared to highly-trained female athletes however we did not measure energy 
intake or expenditure in either population. With this knowledge, it should be 
noted that pRMR equations do not take into account energy intake or 
expenditure, which may contribute to the high variance between different 
populations using the equations.  
A common element of all three prediction equations utilized for comparison in this 
study is they do not take into account physical activity (Weijs, 2008). The Harris-
Benedict equation was developed and validated using predominantly white 
participants (136 male and 103 female) of an average build and body mass (Harris 
& Benedict, 1918). The Mifflin-St Jeor equation was derived from a sample of 498 
average-weight, overweight, obese, and severely obese individuals aged 19 to 78 
(Mifflin et al., 1990), and the WHO equation was mostly derived from young 
European military and police recruits, including 2,279 men and 247 women with 
45% of Italian descent (James, 1985). It is known that greater levels of physical 
activity increase energy expenditure and lean mass, factors which have been 
shown to effect RMR. Thus, the importance of testing the validity of these well-
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established equations in cohorts of varying physical activity levels, as 
demonstrated by the cohorts of the current study. 
The Parvo Medics TrueOne analyser is a reliable tool for measuring RMR in 
recreationally trained female athletes, However, the over-prediction of RMR 
derived from pRMR equations in recreationally trained female athletes, when 
compared to measured RMR values, is a factor to consider when investigating 
energy balance and energy availability. It is important to note also that all the 
pRMR equations showed a significant difference to measured RMR, this could 
suggest a need for new predictive tools that are more accurate to specific 
populations. As RMR is a tool used in the competitive sporting environment to 
determine energy availability and subsequent prevention of relative energy 
deficiency in sport (REDs); additional research in sub-elite female athletes is 










Study 2: Under the radar: A snapshot 
health profile of highly-trained, non-





Purpose: The aim of the current study was to investigate the haematological 
profiles of non-professional highly-trained female athletes. Methods: 13 non-
professional highly-trained female endurance athletes provided a blood test 
where iron markers of haemoglobin (Hb), haematocrit (Hct), C-reactive protein 
(Crp), serum iron, serum ferritin and transferrin were assessed. Methodology also 
included; resting metabolic rate (RMR) assessment, Dual-energy x-ray 
absorptiometry (DXA) scans, diet and training diary, and menstrual cycle tracking 
to assess other female health risks associated with relative energy deficiency in 
sport (REDs). Results: Six of the 13 females were classified as iron deficient (ID). 
Serum iron, serum ferritin, and transferrin were all significantly higher in the non-
iron deficient (non-ID) group when compared to the iron deficient (ID) group (p < 
0.05). Haemoglobin (Hb) and Haematocrit (Hct) were significantly lower in the ID 
group compared with the non-ID group (p < 0.05). Crp and serum iron showed a 
large negative correlation (r = -0.66), Crp and serum ferritin a very large negative 
correlation (r = -0.72) and transferrin presented a large correlation with Crp (r = 
0.70). Conclusion: 46% of this population were diagnosed with iron levels below 
optimal; this could have lasting health effects and impair athletic performance. 
The need for more education and support in non-professional athletes regarding 





Athletes are at an increased risk of iron deficiency due to exaggerated losses 
through haemolysis, sweating, gastrointestinal bleeding, and exercise-induced 
acute inflammation (Auersperger et al., 2013; Ma et al., 2013; Peeling et al., 2008). 
Female athletes are at further risk due to menstrual blood losses and lower dietary 
iron intake (Beard & Tobin, 2000; Hinton, 2014). While many high-performance 
athletes have access to medical professionals to diagnose and treat iron deficiency 
(with and without anaemia), the majority of non-professional female athletes do 
not, increasing the risk of  chronic iron deficiency and the negative health and 
performance implications (Beard, 2001; Nazem & Ackerman, 2012; Petkus et al., 
2017; Wade & Jones, 2004). Exactly how prevalent iron deficiency is among female 
athletes is not known, but some research suggests this number could be as high 
as 50% in endurance athletes (Hinton, 2014). According to the USA Department of 
Health & Human Services (2017), the prevalence of iron deficiency in the general 
premenopausal female population is roughly 9%. A 2011 study of female 
collegiate rowers found 10% of the athletes were anaemic and 30% had iron stores 
below optimal level (DellaValle & Haas, 2011). 
The increased incidence of iron deficiency in female endurance athletes is thought 
to be the result of low dietary iron intake in this population, losses of iron in 
menstrual blood, sweat iron loss, and gastrointestinal blood loss (McClung et al., 
2014). However, it may also be related to acute exercise-induced inflammation 
(Peeling, 2010). Hepcidin, an iron-regulatory hormone, has been identified as an 
enzyme of interest in the interplay of inflammation and iron absorption 
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(Auersperger et al., 2012; McClung et al., 2013; Newlin et al., 2012). A single 
session of exercise not only increases inflammatory cytokines, but also elevates 
oxidative stress (Newlin et al., 2012). Post-exercise inflammation has been shown 
to up-regulate hepcidin, which acts to inhibit the absorption of iron (Di Santolo et 
al., 2008; Newlin et al., 2012; Peeling et al., 2009b; Roecker, Meier-Buttermilch, 
Brechtel, Nemeth, & Ganz, 2005; Sim et al., 2013; Sim et al., 2012). Hepcidin acts 
to block iron efflux from various cell types by binding to the iron transporter 
ferroportin and down-regulating its expression, in both inflammatory states and 
in response to increased levels of circulating iron (Nicolas et al., 2002). Among 
inflammatory markers, Crp is the most clinically useful and the best markers of 
inflammation, and is often used in athletic populations as chronic low grade 
inflammation is  associated with prolonged exercise (Kazeem, Olubayo, & Ganiyu, 
2012). 
Female athletes participating in regular training programmes with insufficient 
caloric intake are at risk of a state of chronic low energy availability (LEA). This LEA 
can also contribute to stage 1 iron deficiency (Suominen, Punnonen, Rajamaki, & 
Irjala, 1998) and may contribute to menstrual cycle dysfunction, compromised 
reproductive function, impaired bone health and thyroid function, and impaired 
athletic performance (Petkus et al., 2017). 
The aim of the current study was to investigate prevalence of iron deficiency in a 
non-professional highly-trained population of female endurance athletes. As the 
research in this cohort is limited, we aimed to get a snapshot of their current 





Twenty non-professional, highly-trained, premenopausal female endurance 
athletes (mean ± SD: age: 32 ± 7 y, training volume: 18.5 ± 4.1 hrs) volunteered to 
participate in this study. Women were initially excluded if they did not meet the 
following criteria: a) regular menstrual cycles (24-35 days in length) or using a 
contraceptive (monophasic pill or intrauterine device) for >6 months before 
entering the study, b) represented New Zealand at an elite level within the past 
three years and currently participating on a regular basis in competitive 
endurance-sport activity (running, cycling, triathlon), c) have no current or recent 
(<3 months) injury or illness, or chronic disease, d) are not pregnant or not 
planning to become pregnant, and e) non-smoking. All participants provided 
informed written consent and the study received ethical approval from the 
Institutions Human Research Ethics Committee.  
Food & training diaries 
Participants recorded all diet and fluid intake, and training over seven days on an 
online diet program (MyFitnessPal, UnderArmour, Baltimore, MD, USA) and 
exercise (TrainingPeaks, Boulder, CO, USA) platforms. They were provided  with 
verbal and written instructions for accurate recording of all foods and fluids 
consumed. Once the subjects submitted their diaries, a dietitian checked the food 
records and confirmed the contents, clarifying specific items and/or detailed 
information as necessary. Dietary analysis of the food diaries was conducted using 
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food analysis software (NutriBase Pro 17, CyberSoft Inc, Phoenix, AZ, USA). 
Training hours at intensity was classified as all training done above 80% VO2max and 
calculated upon analysis of training logs using heart rate-based training impulse 
(TRIMP).  
Determination of menstrual cycle 
Participants used the mobile application HelloClue (Version 3.7.1, BioWink GmbH, 
Berlin) to keep track of cycle length over the course of three full menstrual cycles. 
For those individuals using an oral contraceptive pill or intrauterine device, the 
brand and history of use was noted.  
Blood samples 
Blood samples were collected following an overnight fast (6:30 p.m. to 8:00 a.m.). 
All blood samples were obtained via an antecubital vein while in a seated position. 
After drawing blood, serum and plasma samples were obtained after 
centrifugation (3000 rpm, 10 min, 4 °C) and stored at −80 °C until analysed. 
The sex hormone profile (oestrogen, progesterone, testosterone, follicular 
stimulating hormone [FSH], luteinizing hormone [LH], and beta-human chorionic 
gonadotropin [β-hCG]); DHEA-S, cortisol, iron-status variables (iron, ferritin, 
transferrin), and a marker of inflammation (Crp) were analysed at the local health-
board utilised medical laboratory.  
Plasma oestrogen was measured via a Sorin (sensitive) RIA kit (Sorin Biomedica 
Diagnostics, Saluggia, Italy). Progesterone was measured using the commercial 
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conjugate-antibody method (ELISA kit, Assay Designs, Ann Arbor, MI, USA) with 
sample concentrations determined against a standard curve. Intra- and inter-assay 
coefficients of variation, respectively, for the midrange standards were for plasma 
oestrogen (115 pg·ml-1) 2.80% and 6.00%, and progesterone (1.5 ng·ml-1) 3.61% 
and 4.80%. Testosterone, cortisol and DHEA-S concentrations were measured by 
a sensitive and specific liquid chromatography-tandem mass spectrometry assay 
with minor modifications to improve assay specificity. Iron-status variables were 
measured immediately after non-fasting venous blood sampling (antecubital 
venepuncture into two evacuated tubes with EDTA and serum separator) included 
haemoglobin, haematocrit, ferritin, iron, transferrin, and Crp. 
Dual-energy X-ray absorptiometry (DXA) 
A NHANES positioning DXA  (Hologic Discovery DXA, Hologic Inc Bedford, MA, USA) 
scan was used to assess body composition and in particular percent body fat, fat 
mass, lean body mass and bone mineral density. Participants underwent an 
anthropometrical analysis of height (to the closest 0.1 cm) using a medical 
stadiometer (Harpenden, Holtain Limited, Crymych, UK) and mass (to the closest 
0.1 kg) on medical scales (WM202, Wedderburn, Bilinga, Australia) prior to 
undergoing a body composition scan on the DXA.  On the morning of the scan, the 
participant confirmed they had fasted overnight; rested and refrained from 
strenuous exercise for the previous 24 hrs; wore minimal clothing; bladder voided; 
as well as jewellery and metal removed, prior to scanning (De Souza et al., 2008; 




All data is presented as mean ± SD unless stated otherwise. Statistical significance 
was set at p < 0.05. Comparison of the ID and non-ID groups was achieved using a 
Students’ unpaired t-test and Cohen’s effect sizes (d). The effect sizes were 
determined using an excel spreadsheet (Hopkins, 2007). The magnitude of effect 
sizes was assessed with the following thresholds: <0.2, trivial; 0.2-0.6, small; 0.6-
1.2, moderate; 1.2-2.0, large; 2.0-4.0, very large; >4.0, extremely large (Hopkins, 
Marshall, Battherham, & Hanin, 2009). Pearson’s correlations (r) were used to 
examine associations between variables. The magnitude of correlation between 
variables was assessed with the following thresholds: <0.1, trivial; <0.1-0.3, small; 
<0.3-0.5, moderate; <0.5-0.7, large; <0.7-0.9, very large; and <0.9-1.0, almost 
perfect (Hopkins, 2002). 
Results 
Of the 13 women who were included in this study, six were classified as iron 
deficient (ID) and 7 were classified as non-iron deficient (non-ID) based on a 
threshold of <30 ug/L serum ferritin indicating ID (Suominen et al., 1998). Dietary 
intake of iron between groups was not significantly different (ID: 13.99 ± 6.26; 
non-ID: 14.20 ± 5.22 mg×day-1). Characteristics for each group are detailed in Table 
7. Crp was elevated in the ID group (p = 0.0001, d = -3.33 ± 0.93, very large), as 
was transferrin (p = 0.004 d = -1.82 ± 0.91, large). Serum ferritin (p = 0.002, d = 
1.97 ± 0.92, large), serum iron (p = 0.011, d = 1.55 ± 0.91, large), haemoglobin (Hb) 
(p = 0.036, d = 1.24 ± 0.94, large) and haematocrit (Hct) (p = 0.034, d = 1.27 ± 0.92, 
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large) were all significantly lower in the ID group when compared with the non-ID 
group (Table 9).  
When compared with normative data (Table 8); serum ferritin (ID = 27.5 ± 2.8 ug/L, 
non-ID = 41 ± 7.3 ug/L), serum iron (ID = 20.5 ± 1.0 mmol/L, non-ID = 25.5 ± 
3.4mmol/L), cortisol (ID = 359.3 ± 112.4 nmol/L, non-ID = 320.8 ±  96.4 nmol/L) 
and Hb (ID = 130.5 ± 7.8 g/L, non-ID = 143.8 ± 8.4 g/L) were all within normal ranges 
in both ID and non-ID cohorts. Transferrin was higher than normal in the ID group 
(3.9 ± 0.1 g/L) but the non-ID group (3.1 ±  0.6 g/L) remained within the normal 
range. Crp was elevated above the normal range in both ID (2.8 ± 0.5 mg/dL) and 
non-ID athletes (0.8 ± 0.6 mg/dL).  
Correlations between measured variables are shown in Table 10. There was a very 
large correlation between serum iron and Crp (r = -0.72, Fig 3a). Large correlations 
were also seen between Crp and serum ferritin (r = -0.66) and Crp with transferrin 
(r = 0.70). Training hrs×wk-1 showed a large correlation with measured RMR (r = -
0.66) and intensity hrs×wk-1 correlated well with BMD (r = 0.68, Fig 3b). Cortisol 




Figure 3. The correlation between health markers in highly-trained female 
endurance athletes: (a) serum iron vs C-reactive protein (Crp); b) bone mineral 




 Table 7. Participant Characteristics (grouped by iron status, iron deficient (ID) & non-iron deficient (non-ID)).  
 
  
 ID  (n=6) Non ID   (n=7) 
Age (yrs) 31 ± 3 34 ± 10 
Height (cm) 170.7 ± 2.4 164.2 ± 6.8 
Body Mass  (kg) 62.6 ± 7.5 58.8 ± 5.7 
Body Fat (%) 21.0 ± 6.2 18.8 ± 5.0 
BMI 21.6 ± 2.3 21.9 ± 1.7 
Training (hrs/wk) 17 ± 5 20 ± 3 




Table 8. Iron deficient (ID) and non-iron deficient (non-ID) haematological markers compared to normal ranges. 
 ID                   
(mean ± SD) 
Non-ID                  
 (mean ± SD) Normal Ranges* 
Serum Ferritin (ug/L) 27.5 ± 2.8 41 ± 7.3 15-200 
Serum Iron (mmol/L) 20.5 ± 1.0 25.5 ± 3.4 11-29 
Transferrin (g/L) 3.9 ± 0.1 3.1 ± 0.6 2.1-3.6 
Crp (mg/dL) 2.8 ± 0.5 0.8 ± 0.6 <0.5 
Cortisol (nmol/L) 359.3 ± 112.4 320.8 ± 96.4 251-552 
Hb (g/L) 130.5 ± 7.8 143.8 ± 8.4 120-160 





Table 9. Comparison of haematological profiles, bone mineral density (BMD) and resting 





ID                     
(mean ± SD) 
Non ID              
(mean ± SD) 
P-Value                    
(p) 
Effect Size        
(mean ± 90% 
CI) 
Serum Ferritin (ug/L) 27.5 ± 2.8 41.0 ± 7.3 0.002* 1.97  ± 0.92 (large) 
Serum Iron (mmol/L) 20.5 ± 1.0 25.5 ± 3.4 0.011* 1.55 ± 0.91 (large) 
Transferrin (g/L) 3.9 ± 0.1 3.1 ± 0.6 0.004* -1.82 ± 0.91 (large) 
Crp (mg/dL) 2.8 ± 0.5 0.8 ± 0.6 0.0001* -3.33 ± 0.93 (very large) 
Cortisol (nmol/L) 359.3 ± 112.4 320.8 ± 96.4 0.373 -0.47 ± 0.95 (unclear) 
Hb (g/L) 130.5 ± 7.8 143.8 ± 8.4 0.036* 1.24 ± 0.94 (large) 
Hct (g/L) 0.392 ± 0.01 0.430 ± 0.02 0.034* 1.27 ± 0.92 (large) 
FSH (mU/mL) 4.8 ± 1.2 22.0 ± 33.5 0.2952 0.56 ± 0.90 (unclear) 
LH (mU/mL) 6.0 ± 3.9 17.7 ± 20.1 0.3099 0.60 ± 0.92 (unclear) 
Preogesterone 
(ng/mL) 
2.5 ± 1.7 5.0 ± 4.0 0.306 0.55 ± 0.99 (unclear) 
Oestradiol (pmol/L) 1037.3 ± 618.6 733.0 ± 411.4 0.271 -0.67 ± 1.18 (unclear) 
Testosterone 
(nmol/L) 
1.2 ± 0.8 1.7 ± 0.6 0.303 0.55 ± 0.95 (unclear) 
BMD 1.2 ± 0.1 1.2 ± 0.1 0.7 -0.20 ± 0.96 (unclear) 
RMR (kcal) 1581.7 ± 84.2 1670.9 ± 247.9 0.42 0.43 ± 0.91 (unclear) 




Table 10. Pearson’s correlations between measured blood markers, bone mineral density (BMD), and resting metabolic rate (RMR) in highly-
trained, non-professional female athletes. 
Magnitude of correlation = *Moderate, **Large, ***Very large. BF – body fat, RMR – resting metabolic rate, Crp – C-reactive protein, Hb – Haemoglobin, Hct – Haematocrit, 
BMD – bone mineral density. 
 
Body 




Iron Transferrin Crp BMD Progesterone Oestradiol Age Hct Hb 
Training 
hrs/wk 
% BF 0.60**               
RMR 0.14 -0.09              
Cortisol 0.41* -0.01 -0.49*             
Serum 
Ferritin -0.21 -0.32* 0.11 0.06            
Serum Iron 0.03 -0.21 0.45* -0.11 0.70**           
Transferrin 0.40* 0.38* -0.48* 0.53** -0.23 -0.45*          
Crp 0.04 0.13 -0.52 0.31* -0.66** -0.72*** 0.70**         
BMD 0.66** 0.23 0.12 0.48* 0.03 0.16 0.16 -0.11        
Progesterone 0.14 -0.38* 0.14 0.43* 0.58** 0.61** -0.1 -0.31* 0.46*       
Oestradiol 0.13 0.4 -0.33* 0.09 -0.29 -0.11 0.42* 0.34* 0.33* -0.53**      
Age 0.02 0.18 -0.20 -0.13 0.37* 0.31* 0 -0.3 -0.37* 0.17 -0.37*     
Hct -0.24 -0.21 0.08 -0.15 0.81*** 0.71*** -0.21 -0.44* -0.19 0.28 -0.02 0.32*    
Hb -0.09 -0.13 0.15 -0.22 0.75*** 0.74*** -0.22 -0.5 -0.19 0.2 -0.03 0.45* 0.95***   
Training 
hrs/wk 0.1 -0.23 
-
0.66** 
0.31* 0.13 0.04 0.2 0.25 0.06 0.24 0.05 0.26 0.27 0.27  
Intensity 
hrs/wk 0.3 -0.13 -0.34 0.48* 0.18 0.24 0.15 0.03 0.68** 0.48* 0.21 -0.06 0.1 0.12 0.7 




While the main outcome of this study was to examine the biochemical profile in a 
cohort of non-professional highly-trained female athletes, interesting correlations 
between health markers were also identified that that should be further 
investigated. Based upon the threshold of <30 ug/L serum ferritin indicating early 
stages of ID (Suominen et al., 1998), 46% (n=6) of the female endurance athletes 
measured presented with iron deficiency. This is similar to what has been 
previously reported in other endurance based studies (Constantini et al., 2000; 
DellaValle & Haas, 2011; McClung, Marchitelli, Friedl, & Young, 2006). While many 
studies differ in specific identification thresholds for diagnosing iron deficiency, 
ranging from <12 to <35 ug/L serum ferritin (Burden et al., 2015; Di Santolo et al., 
2008; Milic et al., 2011; Pate et al., 1993; Peeling et al., 2007), it has been 
suggested that athletes, especially endurance trained athletes, are more at risk of 
iron depletion through increased losses and often inadequate intake. Therefore, 
the threshold for iron deficiency should be higher to support optimal function and 
performance (Whiting & Barabash, 2006).  
This study provides an insight into the health profiles of a group non-professional 
highly-trained female endurance athletes. While it has been identified in the 
literature that female athletes are at risk of health problems related to increased 
activity levels and/or inadequate diet (Day et al., 2015; De Souza & Williams, 2004; 
Kim & Nattiv, 2016; McClung et al., 2014), there is a gap in knowledge on highly-
trained, non-professional female athletes. Much of the studied population has 
been recreationally-active females (Alaunyte et al., 2014; Choe et al., 2001; Pate 
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et al., 1993; Sinclair & Hinton, 2005; Spodaryk et al., 1996) who are not under the 
same intensive training loads that the athletes of the current study. Alternatively 
there is also a paucity of research in collegiate/professional athletes (Clement & 
Sawchuk, 1984; DellaValle & Haas, 2011; Ostojic & Ahmetovic, 2008; J.  Reed et 
al., 2013; Schaal et al., 2017), however they have the benefit of increased 
awareness of athlete focused health problems and a team of professionals with 
knowledge of such issues. According to the classification system in Decroix, De 
Pauw, Foster, and Meeusen (2016), the female athletes in the current study 
matched the training load of the PL5 category (>17hrs×wk-1), whereby athletes 
were described as professional. There is limited research determining the 
difference between highly-trained athletes and professional athletes, especially in 
females. However, due to the matched training loads, these athletes may have a 
higher chance of developing clinical health issues from heavy training loads paired 
with inadequate support from high-performance support staff (medical, 
dieticians, physiologists, biomechanists/strength and conditioning coaches, 
psychologists).  
As noted in other iron studies (Ahmadi et al., 2010; Constantini et al., 2000; Di 
Santolo et al., 2008; Malczewska et al., 2001) we observed an increase in 
transferrin and a decrease in serum iron, serum ferritin, Hb and Hct in the ID group 
(stage 1 iron deficiency). Crp was also higher in this group, which supports the 
current theory that inflammation plays a key role in the absorption of iron 
(Auersperger et al., 2012; Nicolas et al., 2002; Peeling et al., 2008; Peeling et al., 
2009a). Although significantly different between groups (p < 0.05), when these 
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iron parameters were compared with current clinical guidelines (Wians, 2018), 
none of the participants would have been classified as iron deficient.  
Through further analysis of the biochemical profiles in our study we also observed 
some correlations of interest. Crp showed a strong negative correlation with 
serum iron and was also well correlated with serum ferritin and transferrin, again 
supporting claims in recent research that inflammation could have a deleterious 
effect on iron absorption (Auersperger et al., 2012; Nicolas et al., 2002; Peeling et 
al., 2008; Peeling et al., 2009a).  
One novel concept of the current study was the unique population studied: a non-
professional, highly-trained cohort of female endurance athletes. Growing 
evidence of iron deficiency in athletic populations warrants a re-evaluation of 
screening and the thresholds that results are being screened against. Our research 
suggests the female athletes in the current study could be misdiagnosed in normal 
healthcare settings based on the clinical guidelines that we compared our results 
to in Table 8. Recent reviews support this finding suggesting there are benefits to 
the monitoring of iron levels in athletes (Alaunyte, Stojceska, & Plunkett, 2015; 
Pedlar, Brugnara, Bruinvels, & Burden, 2017) as even the early stages of a 
deficiency could have a disadvantageous effect on aerobic exercise performance 
(DellaValle & Haas, 2011). 
This research adds to the evident need for an athlete-centred set of guidelines 
when identifying health issues such as iron deficiency. 46% of the athletes in the 
current study were identified as iron deficient below levels for optimal function. 
To avoid long-term health problems and enhance athletic performance, athletes 
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that are training at high levels below professional status need the same education 




































Frequently, health-related research is generalized from a less-trained or 
sedendary population to an elite population, which may only be appliciable to the 
specific population studied. The aim of this thesis was to examine the health status 
in an under-represented cohort of female athletes and build upon the literature 
to provide more knowledge and awarenes to both practioners working with 
female athletes and the athletes themsleves. The first study of this thesis reported 
RMR values for  recreational vs elite female athletes; whereby the validity of RMR-
preditive equations and laboratory techniques were examined in both 
populations. The second study of this thesis aimed to investigate specific health 
parameters related to iron, resting metabolic rate and energy balance in a cohort 
of female athletes: those women who train and race on the world stage, yet do 
not have the (allied health) support staff that a professional athlete might access. 
This cohort may be at a higher risk of developing clinical health issues, such as iron 
deficiency, as demonstrated in the population studied in this thesis.  
The first study, examined the the validity of three pRMR equations against 
measured RMR and investigated the reliability of measured RMR using the 
TrueOne metabolic analyser (TrueOne 2400, Parvo Medics, Sandy UT). Although a 
small cohort, the Parvo Medics TrueOne analyser was determined to be a reliable 
tool for measuring RMR in recreationally-trained female athletes. Conversely, the 
validity of all three predictive equations when compared to measured RMR was 
questionable, with low levels of agreement. When grouped by training status, it 
was determined that the 3 equations underestimated RMR in the sub-elite female 
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athlete population by approximately 131-139 kcal×day-1 but overestimated RMR in 
the recreationally-active females by approximately 148-162 kcal×day-1. The 
predictive equation demonstrating the highest levels of agreement with measured 
RMR in both the recreationally-active and sub-elite female athletes was the Mifflin 
St. Jeor equation. As RMR is a tool used in the competitive sporting environment 
to determine energy availability and useful in the prevention of relative energy 
deficiency in sport (REDs); additional validation research in highly-trained female 
athletes is warranted.  
 As women are superseding men in endurance sport participation (da Fonseca-
Engelhardt et al., 2013), a unique population is emerging that does not fit the 
definition of recreationally-active or elite. The second study of this thesis aimed to 
investigate specific health parameters in this unique population to determine iron 
status, resting metabolic rate, inflammation, and energy balance. Of the 13 
women who were included in this study, six were classified as iron deficient (ID) 
and seven were classified as non-iron deficient (non-ID). Training hrs×wk-1 showed 
a large correlation with measured RMR (r = -0.66, large) and intensity training ( 
>80% VO2max) hrs×wk-1 also had a large correlation with BMD (r = 0.68, large). 
Results also suggested that clinical reference ranges for haematological measures 
may be inappropriate for this athletic population, as iron status should be higher 
for optimal performance. Moreover, this population of highly-trained, non-
professional female athletes need additional support in understanding and 




The outcomes of these studies aid in furthering the knowledge base surrounding 
female athlete health, more specifically in non-professional highly-trained female 
athletes. From the research conducted in the current studies, it was concluded 
that predictive RMR equations should be used with caution due to the risk of 
under-predication of true energy availability in female athletes. Another health 
concern of this population is iron deficiency. This thesis demonstrates the 
prevalence of sub-optimal iron status in highly-trained female endurance athletes. 
Furthermore, the haematological profile of this population should be assessed 
with the knowledge that they are highly-active and optimal ranges for iron status 
may differ from the current clinical guidelines (Wians, 2018). As the cohort 
investigated in this thesis was small, further work is needed to validate and expand 
the knowledge base to inform health practices in highly-trained female athletes. 
The following recommendations are made for future research: 
Future research  
Measurement of RMR  
• Research across a larger population of highly-trained athletes, both male 
and female, would be beneficial to further examine the validity of pRMR 
equations. 
• There is also still limited knowledge on pre-test protocols. While most 
research suggests an overnight fast of at least 6-hours and no high intensity 
physically activity within 14-hours of testing (Compher et al., 2006), more 
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research in an athletic population may be beneficial, specifically addressing 
the effect that exercise has on RMR measurement as this is a large factor 
when testing athletes who are participating in set training regimes.  
Health of highly-trained, non-professional  female athletes 
• Research on a more extensive population of highly-trained female 
athletes across a wide range of sports to expand the knowledge and 
literature base of this unique cohort would be beneficial. This can then 
be used to inform health practitioners and athletes alike of the unique 
risks afforded to them. 
• There is still no clear set of guidelines for diagnosis of iron deficiency in 
athletes both female and male. The current standards applied to the 
female athlete are based upon a haemoglobin limit of 120 g/L (Van den 
Bosch et al., 2001), which is not applicable to the highly-trained female 
as training adaptations and the act of exercise itself, alters 
haematological parameters (Branch et al., 1997; Hu & Lin, 2012; 
Weight, Alexander, Elliot, & Jacobs, 1992).  
• Oral contraceptives (OC) add complexity through the introduction of 
varying concentrations of circulating exogenous oestrogen and 
progesterone; which may moderate physiological adaptations to 
exercise differently than endogenous ovarian hormones, thus 
investigating  and comparing health parameters of women on 
hormonal contraceptive to women who are naturally cycling should be 
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Appendix 2 – Participant information 
Document 1 – Survey information 
 
SURVEY INFORMATION SHEET FOR FEMALE ATHLETE PARTICIPANTS 
THE UNIVERSITY OF WAIKATO, Faculty of Education 
A multidisciplinary project on the physiological health issues facing female 
athletes 
Surveys 
You will complete a short paper survey to gather: 
1. Basic demographic information (~5 minutes) including: 
i. Age 
ii. Sport/event 
iii. Years competing in your sport 
iv. Highest achievements to date 
 
Using MyFitness Pal: 
2. Training information including: 
i. Weekly training schedule 
ii. Training duration and intensity 
iii. Training modes  
3. Standard dietary tracker to record energy intake across one (1) full week to 
include the weekend days (~30 minutes/day) including: 
i. Meals and snacks of choice and frequency 
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ii. Fluid consumption 
iii. Recovery nutrition 
iv. Menstrual Cycle Status 
 
Confidentiality 
As a participant in this project, you will remain anonymous in any materials 
produced from the research. Please let us know if you would be happy to be 
partially identified (e.g., age, sport) in our publications. See details regarding full 
confidentiality and partial disclosure on the informed consent form. The data 
collected will be used in research articles and presentations. Research articles will 
be published in academic journals and will be read mostly be university students, 
researchers, academics and sport and health professionals. The data will be 
presented to groups within universities and perhaps at academic conferences. 
 
Participants’ Rights 
As a participant you have the right to: 
• Discuss any concerns you have about the collection of the survey information 
• Refuse to answer any particular question in the surveys 
• Ask any further questions about the study which occur during your participation. 
• Withdraw from the project at any time. 
• Be given access to your survey information and to a summary of the findings 
from the study when it is concluded. Please provide a physical address or email 
address on the Informed Consent Form so that we can send you a copy of 
your results 
Records 
All records from the surveys will be kept confidential. They will be archived for at 
least five years according to University of Waikato Human Research Ethics 





Document 2 – RMR and DXA information 
 
RESTING METABOLIC RATE (RMR) ASSESSMENT and BODY COMPOSITION 
INFORMATION SHEET FOR FEMALE ATHLETE PARTICIPANTS 
THE UNIVERSITY OF WAIKATO, Faculty of Education 
A multidisciplinary project on the physiological health issues facing female 
athletes 
Resting Metabolic Rate (RMR) assessment (~30 minutes) 
 
A RMR assessment will be conducted to establish your current energy availability 
status. For this assessment, you will be required to arrive at your chosen testing 
venue around 0730 following an overnight fast (nothing from 10pm the night 
before, except water). You will also be asked to refrain from exercising the day 
before.   
 
Upon arrival, we will obtain your height and weight prior to the RMR assessment. 
You will be required to lie still and awake during the test. During this time, we will 
measure the amount of oxygen you consume and carbon dioxide you produce 
while lying down. To measure the expired gas, a ventilated hood will be placed 
you’re your head (Figure 1) for 15 minutes, which will be connected to a breath-








Figure 1. Example of a participant under a ventilated hood to measure resting 




Body Composition - Dual-energy X-ray absorptiometry (DXA) (~30 minutes) 
 
If you have been identified with energy deficiency via the RMR assessment, you 
will be referred Bay Radiology to complete a DXA scan to assess your body 
composition. For this assessment, your fat mass, lean body mass, and bone health 
will be measured.  
 
DXA provides the gold-standard assessment of body composition and is routinely 
used in Triad/RED-S related investigations to further detail energy deficiency 
status and bone health. It is non-invasive and painless. For this assessment, you 
will lay on your back on the DXA scanner bed for ~ seven minutes while the 
machine scans your body overhead from your head to your feet. The machine 
sends an invisible stream of low dose x-rays through your body via two energy 
streams. One is absorbed by soft tissues such as muscle, tendons and fat, the 
other by bone. Comfortable clothes should be worn, or a gown can be provided. 
You will be asked to remove any items that contain metal such as under wire bras, 
pants or shirts that have rivets or eyelets, belts, zips, buckles, and jewelry.  
 
Body composition assessed using a DXA scan involves exposure to X-ray 
radiation. However, the amount of radiation used is very small. It is less than one 
tenth the dose of a standard chest x-ray. The risk will also be minimized by using 
trained professionals to carry out this assessment. 
 
Confidentiality 
As a participant in this project, you will remain anonymous in any materials 
produced from the research. Please let us know if you would be happy to be 
partially identified (e.g., age, sport) in our publications. See details regarding full 
confidentiality and partial disclosure on the informed consent form. The data 
collected will be used in research articles and presentations. Research articles will 
be published in academic journals and will be read mostly be university students, 
researchers, academics and sport and health professionals. The data will be 
presented to groups within universities and perhaps at academic conferences. 
 
The results from your RMR (and DXA if referred) will be given only to you: it is up 
to you whom you decide to share this information with. 
 
Participants’ Rights 
As a participant you have the right to: 
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• Discuss any concerns you have about the collection/storage/disposal of your 
results. 
• Withdraw from the project at any time. 
• Ask any further questions about the study which occur during your participation. 
• Be given access to your physiological data and to a summary of the findings 
from the study when it is concluded. Please provide a physical address or email 
address on the Informed Consent Form so that we can send you a copy of your 
results.        
 
Records 
All records from the physiological testing will be kept confidential. They will be 
archived for at least five years according to University of Waikato Human Research 





Document 3 – Blood sample information 
 
BLOOD SAMPLE INFORMATION SHEET FOR FEMALE ATHLETE PARTICIPANTS 
THE UNIVERSITY OF WAIKATO, Faculty of Education 
A multidisciplinary project on the physiological health issues facing female 
athletes 
Blood Samples (~20min) 
 
Blood work will be important to identify key hormonal changes to identify whether 
you are at risk of RED-S symptoms.  
 
Blood samples will be collected to determine your sex hormone profile, specifically 
cortisol, dehydroepiandrosterone (DHEA), and C-reactive protein (Crp). In female 
athletes with increased-elevated cortisol, there is a potential for menstrual cycle 
changes with the conversion of progesterone, estrogen, and testosterone to 
cortisol. Moreover, DHEA plays a role as it is involved in the synthesis of estrogen, 
progesterone, and testosterone in both men and women. Crp is a marker of 
inflammation which may indication poor absorption of iron. 
 
For this assessment, you will be seated in a sterile area of the lab prepared for a 
venepuncture of an arm vein. The insertion of a sterile needle, can sometimes 
cause discomfort, however a certified phlebotomist will do their best to prevent this. 
Once the needle is inserted into your vein, the extraction of blood is painless. 
Approximately 30 ml will be collected for this project (3x 10ml tubes).  
 
When the blood has been collected, the needle will be removed, and pressure will 
be applied to the site to prevent further bleeding and bruising.  
 
There are minimal risks associated with the collection of blood for this project via 




2. Swelling, tenderness and inflammation at the site 
3. Persistent bleeding 
4. Vasovagal response – dizziness, sweating, coldness of skin, numbness 
and tingling of hands and feet, nausea, vomiting, possible visual 
disturbance, syncope (temporary loss of consciousness caused by a drop 
in blood pressure), and injury fall from fainting.  
 
The risks are minimized by drawing minimal amount of blood for analysis, using a 
certified phlebotomist and following health and safety protocols. Special 
precautions to use sterile equipment and lab spaces, and to have a physician on 
call in case any adverse effects occur, will be implemented.  
 
Analysis  
All blood samples will be separated into four aliquots for analysis; one will be used 
immediately to measure hematocrit and hemoglobin, the rest will be transferred 
into tubes and spun to separate whole blood from serum. The serum will be 
separated and frozen for storage and transport, for analysis of sex hormones, 
cortisol, DHEA and Crp, later. The analyses will take place at PathLab, Tauranga. 
If you would like your samples returned, please let the research team know, 




As a participant in this project, you will remain anonymous in any materials 
produced from the research. Please let us know if you would be happy to be 
partially identified (e.g., age, sport) in our publications. See details regarding full 
confidentiality and partial disclosure on the informed consent form. The data 
collected will be used in research articles and presentations. Research articles will 
be published in academic journals and will be read mostly be university students, 
researchers, academics and sport and health professionals. The data will be 
presented to groups within universities and perhaps at academic conferences. 
 
The results from your blood work will be given only to you: it is up to you whom you 
decide to share this information with. If abnormal results are noted, you will be 
notified and referred to see your general practitioner or team doctor. 
Participants’ Rights 
As a participant, you have the right to: 




• Refuse to answer any particular question 
• Withdraw from the study at any time. 
• Ask any further questions about the study which occur during your participation. 
• Be given access to your physiological data and to a summary of the findings 
from the study when it is concluded. Please provide a physical address or email 
address on the Informed Consent Form so that we can send you a copy of your 
results.        
 
Records 
All records from the physiological testing and interviews will be kept confidential. 
They will be archived for at least five years according to University of Waikato 
Human Research Ethics Regulations, but it is expected they will be appropriately 















Appendix 3 – Informed consent  
 
INFORMED CONSENT FORM 
THE UNIVERSITY OF WAIKATO, Faculty of Education 
A multidisciplinary project on the physiological health issues facing female 
athletes 
 
I have read the Information Sheet for Female Athlete Participants Documents 
for this study and have had the details of the study explained to me. My questions 
about the study have been answered to my satisfaction and I understand that I 
may ask further questions at any time. 
 
I agree to participate under the conditions set out below: 
 
1) A member of the research team will conduct a resting metabolic rate 
assessment to establish current energy availability status. I, the participant, 
have the right to withdraw/with draw data at any time. The referral for the 
DXA scan will only be completed if the research team identify you with 
energy deficiency.  
2) A trained individual will conduct the collection of blood samples. I, the 
participant, have the right to withdraw/withdraw data at any time.  The blood 
samples will be analysed in a clinical laboratory facility, and, if requested, 
samples will be returned to me; otherwise they will be destroyed upon the 
conclusion of the study. 
3) I understand the research team will keep all records from the short paper 
surveys and physiological testing confidential. I understand that all data will 
be archived for at least five years according to University of Waikato Human 
Research Ethics Regulations but will most likely be appropriately disposed 
of before 2022. 
4) The data collected by the research team will be used in research articles 
and presentations. I consent to the data being used for publication 
purposes. I understand that any use of the data will not take place without 
permission from me. 
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5) I understand the implications of choosing full confidentiality or partial 
disclosure, as conditions of confidentiality. Full confidentiality means that 
the researchers will not use my name or any other identifiers in anything 
they publish from this project. Choosing full confidentiality means they will 
identify me solely via the following: female, athlete, age range for the 
project. Partial disclosure means that the researchers will not use my name 
in anything they publish from this project, but I am happy for them to include 
my sporting code and/or specific age. 
6) I understand that I can withdraw from this study at any time. 
7) I understand that I can decline to answer any particular question in the 
study. 
8) I understand that if I have any ethical concerns I can contact either the 
primary researchers, Dr Stacy Sims (email: stacy.sims@waikato.ac.nz) or 
Associate Professor Holly Thorpe (email: holly.thorpe@waikato.ac.nz) or 
Head of the University of Waikato Human Research Ethics Committee, Dr 
Julie Barbour (email: humanethics@waikato.ac.nz) 
 
I agree to provide information for each assessment to the researcher under the 
conditions of confidentiality set out below: 
 
Surveys Full confidentiality [  ] Partial disclosure [  ] 
Resting Metabolic Rate  Full confidentiality [  ] Partial disclosure [  ] 
Body Composition (if referred) Full confidentiality [  ] Partial disclosure [  ] 
Blood samples Full confidentiality [  ] Partial disclosure [  ] 
                      
Complete the relevant details below, adding pseudonym & other adapted 





Date:          
……………………………………………………......................................................... 
 





Current contact details: 
 
................................................................................................................................. 
⎕ Please tick if you would like a copy of the project findings  
 
Email: 
……………………………………………………………………………………………… 
 
